Gapping up
In reaction to earnings/guidance:
- DB +5.6%, CRM +2.3%, FUL +2.2%, TCOM +0.7%
Other news:
- PGEN +3.9% (names new COO)
- STNG +2.7% (reports it purchased its common shares in the open market and exercised a purchase option for an LR2 product tanker that is currently leased)
- MRNS +1.6% (exercises first contract option by the BARDA)
- CTIC +1.5% (Presentation of New Anemia Benefit Data from Pacritinib Program at the Society of Hematologic Oncology (SOHO) Tenth Annual Meeting)
- BIIB +1.1% (Phase 3 results show benefits)
- TLRY +1% (received approval from the Italian Ministry of Health to import and distribute Tilray's medical cannabis oral solution THC25 across the country)
Analyst comments:
- GRCL +8.7% (initiated with a Buy at Citigroup; tgt $12)
- ME +3.4% (initiated with an Outperform at Cowen; tgt $6)
- NKE +0.5% (initiated with an Outperform at RBC Capital Mkts)